Coronavirus drug to be produced from İsoquercetin in Canada

gave | Friday, May 28, 2021 – 17:01 | Last Updated: 28 05 2021 – 17:01

The first phase of clinical trials of isoquercetin against coronavirus in Canada has been successfully completed. Second phase studies were approved by the Canadian Ministry of Health. In Turkey, it was announced that the production of isoquercetin, which has approximately 5 times more improved bioabsorption and approximately 18 times more bioavailability than the quercetin molecule, has started.

The product, which was licensed by the Ministry of Agriculture and started to be produced as a food supplement, includes Vitamin C, Zinc, Vitamin B2, Vitamin K2 and Vitamin D3 in addition to Isoquercetin. Infectious Diseases and Clinical Microbiology Specialist Assoc. Dr. Ümit Savaşçı said, “Isoquercetin is a form of quercetin that is 5 times more advanced and has about 18 times more bioavailability. “Isoquercetin, produced by adding glucose parts (side chain) to the quercetin molecule in the laboratory environment, reaches maximum plasma levels in 15 minutes because it is actively and rapidly absorbed.”

Stating that the Quercetin molecule has been considered safe in the United States since 2003, Assoc. Dr. The warrior said that the molecule is authorized to be used as a food additive in Japan and is used as an antioxidant in many products. Associate Professor. The warrior gave the following information about the molecule:

Quercetin is among the most popular flavonoid supplements. It has neuroprotective, cardioprotective, chemopreventive, antioxidant, anti-inflammatory, antiviral and anti-allergic properties. Its efficacy has been demonstrated.Quercetin is not the dominant form seen in nature and its bioavailability is weak.In many scientific studies, it has been shown that the bioabsorption of isoquercetin can be up to 5 times and its bioavailability up to 18 times.In numerous clinical studies and hundreds of scientific publications, quercetin can be used for both protection in high-risk populations and remdesivir or convalescent Existing evidence has been presented for its use for the treatment of coronavirus patients by assisting pharmacological agents such as plasma.It has been proven that SARS-CoV-2 and other coronaviruses stop cell entry and proliferation, balance coagulation and excessive immune response. It is a pleasing development that it has been produced with national means, because this molecule can be produced in a few centers in the world. Even though I have the BioNTech vaccine, I use quercetin support especially to avoid being affected by the variants.”